Exagen Inc.

Historical 13F Holders

Symbol
XGN
CUSIP
30068X103
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 30068X103 since 12/18/2024, newest first.

Filer % of Class Filed
Parian Ultreia LP 13G 5.3% 5/27/2026
Event 5/22/2026
Chernett Jorey 13G/A Amendment 1 9.9% 5/20/2026
Event 3/31/2026
RTW Investments, LP 13G/A Amendment 6
4.9% 2/17/2026
Event 12/31/2025
NMSIC Co-Investment Fund, L.P. 13G/A Amendment 7
6.0% 2/11/2026
Event 12/31/2025
Chernett Jorey 13G 5.4% 2/4/2026
Event 1/30/2026
RTW Investments, LP 13G/A Amendment 5
7.7% 8/14/2025
Event 6/30/2025
Lytton Laurence W 13G/A Amendment 3 1.0% 8/14/2025
Event 6/30/2025
Cowen Financial Products LLC 13G/A Amendment 1 5.0%
Checked 5% or less
5/12/2025
Event 3/31/2025
NMSIC Co-Investment Fund, L.P. 13G/A Amendment 6
9.8% 4/17/2025
Event 3/25/2025
NMSIC Co-Investment Fund, L.P. 13G/A Amendment 5
12.0% 1/29/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 4 12.4 k $101 k
2026 Q2 58 8.25 M $38.4 M
2026 Q1 61 9.67 M $29.0 M
2025 Q4 83 10.8 M $65.8 M
2025 Q3 65 9.07 M $99.6 M
2025 Q2 56 10.1 M $70.1 M
2025 Q1 41 6.24 M $22.4 M
2024 Q4 44 6.11 M $25.1 M
2024 Q3 37 6.38 M $19.7 M
2024 Q2 39 6.83 M $12.4 M
2024 Q1 37 7.17 M $11.4 M
2023 Q4 36 7.17 M $14.3 M
2023 Q3 30 6.87 M $16.7 M
2023 Q2 29 6.88 M $20.0 M
2023 Q1 31 6.83 M $16.6 M
2022 Q4 34 6.97 M $16.7 M
2022 Q3 42 7.93 M $21.4 M
2022 Q2 51 10.7 M $277 M
2022 Q1 56 9.09 M $73.0 M
2021 Q4 54 8.60 M $100 M
2021 Q3 54 8.78 M $120 M
2021 Q2 55 8.61 M $129 M
2021 Q1 58 8.95 M $156 M
2020 Q4 36 4.49 M $59.8 M
2020 Q3 38 4.28 M $47.0 M
2020 Q2 36 3.61 M $44.7 M
2020 Q1 35 4.25 M $67.8 M
2019 Q4 39 3.90 M $99.0 M
2019 Q3 29 3.58 M $55.5 M